...
首页> 外文期刊>Stem Cells >Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response
【24h】

Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response

机译:人类皮肤来源的前体细胞免疫原性差,并调节同种异体免疫反应

获取原文
获取原文并翻译 | 示例
           

摘要

Human skin-derived precursors (hSKPs) are multipotent somatic stem cells that persist within the dermis throughout adulthood and harbor potential clinical applicability. In this study, we investigated their immunogenicity and immunosuppressive features, both in vitro and in vivo. As such, this study provides a solid basis for developing their future clinical applications. We found that hSKPs express HLA-ABC molecules, but not HLA-DR, rendering them poorly immunogenic. Using a coculture set-up, we could further demonstrate that hSKPs inhibit the proliferation of allogeneic activated T cells and alter their cytokine secretion profile, in a dose-dependent manner. Cotransplantation of hSKP and human peripheral blood leukocytes (PBL) into severe combined immune-deficient mice also showed a significant impairment of the graft-versus-host response 1 week post-transplantation and a drastic increase in survival time of 60%. From a mechanistic point of view, we found that hSKPs require cell contact as well as secretion of soluble inhibitory factors in order to modulate the immune response. The expression/secretion levels of these factors further increases upon inflammation or in the presence of activated T cells. As such, we believe that these features could be beneficial in a later allogeneic clinical setting, because rejection of engrafted allogeneic hSKP might be delayed or even avoided due to their own promotion of a tolerogenic microenvironment.
机译:人皮肤衍生的前体(hSKP)是多能体细胞干细胞,在成年后一直存在于真皮中,具有潜在的临床适用性。在这项研究中,我们研究了它们在体外和体内的免疫原性和免疫抑制特征。因此,这项研究为开发其未来的临床应用提供了坚实的基础。我们发现hSKPs表达HLA-ABC分子,但不表达HLA-DR,使其免疫原性较差。使用共培养设置,我们可以进一步证明hSKP以剂量依赖的方式抑制同种异体活化T细胞的增殖并改变其细胞因子分泌特征。将hSKP和人类外周血白细胞(PBL)共移植到严重的免疫缺陷合并小鼠中,也显示移植后1周移植物抗宿主反应显着受损,存活时间急剧增加60%。从机制的角度来看,我们发现hSKPs需要细胞接触以及可溶性抑制因子的分泌才能调节免疫反应。这些因子的表达/分泌水平在炎症或存在活化T细胞的情况下进一步增加。因此,我们认为这些功能在以后的同种异体临床环境中可能是有益的,因为移植异体hSKP的排斥反应可能会由于其自身对致耐受性微环境的促进而延迟甚至避免。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号